Alchemy Investments Acquisition Corp 1 Units

NASDAQ:ALCYU USA Shell Companies
Market Cap
$127.80K
Market Cap Rank
#28231 Global
#9416 in USA
Share Price
$13.50
Change (1 day)
+0.00%
52-Week Range
$10.96 - $15.00
All Time High
$15.00
About

Alchemy Investments Acquisition Corp 1 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Newark, Delaware.

Alchemy Investments Acquisition Corp 1 Units (ALCYU) - Net Assets

Latest net assets as of September 2025: $438.58K USD

Based on the latest financial reports, Alchemy Investments Acquisition Corp 1 Units (ALCYU) has net assets worth $438.58K USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($9.02 Million) and total liabilities ($8.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $438.58K
% of Total Assets 4.86%
Annual Growth Rate 397.78%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 131630.08

Alchemy Investments Acquisition Corp 1 Units - Net Assets Trend (2021–2024)

This chart illustrates how Alchemy Investments Acquisition Corp 1 Units's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Alchemy Investments Acquisition Corp 1 Units (2021–2024)

The table below shows the annual net assets of Alchemy Investments Acquisition Corp 1 Units from 2021 to 2024.

Year Net Assets Change
2024-12-31 $5.09 Million -95.58%
2023-12-31 $115.20 Million +279181.76%
2022-12-31 $41.25K 0.00%
2021-12-31 $41.25K --

Equity Component Analysis

This analysis shows how different components contribute to Alchemy Investments Acquisition Corp 1 Units's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 655983400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $11.66 Million 228.96%
Total Equity $5.09 Million 100.00%

Alchemy Investments Acquisition Corp 1 Units Competitors by Market Cap

The table below lists competitors of Alchemy Investments Acquisition Corp 1 Units ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Alchemy Investments Acquisition Corp 1 Units's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 115,203,727 to 5,093,571, a change of -110,110,156 (-95.6%).
  • Net income of 4,248,000 contributed positively to equity growth.
  • Share repurchases of 114,357,720 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $4.25 Million +83.4%
Share Repurchases $114.36 Million -2245.14%
Other Changes $-436.00 -0.01%
Total Change $- -95.58%

Book Value vs Market Value Analysis

This analysis compares Alchemy Investments Acquisition Corp 1 Units's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 26.39x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 4612.25x to 26.39x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2021-12-31 $0.00 $13.50 x
2022-12-31 $0.00 $13.50 x
2023-12-31 $11.29 $13.50 x
2024-12-31 $0.51 $13.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Alchemy Investments Acquisition Corp 1 Units utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 83.40%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 2.38x
  • Recent ROE (83.40%) is below the historical average (362.21%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2021 -21.21% 0.00% 0.00x 9.88x $-12.88K
2022 1383.80% 0.00% 0.00x 29.48x $566.69K
2023 2.86% 0.00% 0.00x 1.05x $-8.22 Million
2024 83.40% 0.00% 0.00x 2.38x $3.74 Million

Industry Comparison

This section compares Alchemy Investments Acquisition Corp 1 Units's net assets metrics with peer companies in the Shell Companies industry.

Industry Context

  • Industry: Shell Companies
  • Average net assets among peers: $36,677,338
  • Average return on equity (ROE) among peers: -64.57%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Alchemy Investments Acquisition Corp 1 Units (ALCYU) $438.58K -21.21% 19.58x $10.73 Million
Artius II Acquisition Inc. Class A Ordinary Shares (AACB) $-60.27K 0.00% 0.00x $198.37 Million
Artius II Acquisition Inc. Units (AACBU) $-60.27K 0.00% 0.00x $205.28 Million
Ares Acquisition Corporation II (AACT-UN) $931.34 Million 0.00% 0.08x $399.77 Million
AA Mission Acquisition Corp. (AAM-UN) $-559.90 Million 0.00% 0.00x $349.76 Million
Global Acquisitions Corporation (AASP) $3.80 Million -5.26% 0.34x $15.42 Million
ABV Consulting Inc (ABVN) $8.75K -623.31% 2.50x $461.96K
Atlantic Coastal Acquisition Corp II (ACAB) $-8.52 Million 0.00% 0.00x $2.44 Million
Annabidiol Corp (ACBD) $-501.57K 0.00% 0.00x $13.62K
ACRO Biomedical Co Ltd (ACBM) $685.87K -17.12% 0.46x $30.04K
Huaizhong Health Group Inc (ADAD) $-19.47K 0.00% 0.00x $3.15K